Showing results (201-210 of 227) with videos related to

Sort By:
Pageof 23
Annals of Neurology|July 30, 2026
Two Years of Ocrelizumab Treatment in Black and Hispanic People with Multiple Sclerosis in CHIMES: A Single-Arm Clinical TrialLilyana Amezcua, Anthony T Reder, Evanthia Bernitsas, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2019
Neutrophils promote VLA-4-dependent B cell antigen presentation and accumulation within the meninges during neuroinflammationChelsea R Parker Harp, Angela S Archambault, Matthew Cheung, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 4, 2021
Bcl6 controls meningeal Th17-B cell interaction in murine neuroinflammationMaike Hartlehnert, Anna-Lena Börsch, Xiaolin Li, et al.
Annals of Neurology|July 4, 2024
Unexpected Low Rate of Amyloid-β Pathology in Multiple Sclerosis PatientsMatthew R Brier, Suzanne E Schindler, Amber Salter, et al.
Neurology. Clinical Practice|May 1, 2018
Effectiveness of alternative dose fingolimod for multiple sclerosisErin E Longbrake, Daniel Kantor, Siddharama Pawate, et al.
The New England Journal of Medicine|August 7, 2020
Ofatumumab versus Teriflunomide in Multiple SclerosisStephen L Hauser, Amit Bar-Or, Jeffrey A Cohen, et al.
Science Translational Medicine|November 30, 2022
A single-cell analysis framework allows for characterization of CSF leukocytes and their tissue of origin in multiple sclerosisPatrick Ostkamp, Marie Deffner, Andreas Schulte-Mecklenbeck, et al.
The Journal of Experimental Medicine|February 3, 2016
IL-1-induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammationChih-Chung Lin, Tara R Bradstreet, Elizabeth A Schwarzkopf, et al.
Plos One|September 1, 2010
Ezrin is highly expressed in early thymocytes, but dispensable for T cell development in miceMeredith H Shaffer, Yanping Huang, Evann Corbo, et al.
Pageof 23